Vol. 36 No. 3 (2019): June
Clinical Expreience

Pediatric pyomyositis: Experience in a Pediatric Reference Center in Argentina

María Eugenia Pannunzio
Hospital de Niños Ricardo Gutiérrez; Universidad de Buenos Aires
M. Laura Praino
Hospital de Niños Ricardo Gutiérrez; Universidad de Buenos Aires
Carolina M. Carballo
Hospital de Niños Ricardo Gutiérrez; Universidad de Buenos Aires
Ana C. Medranda
Hospital de Niños Ricardo Gutiérrez; Universidad de Buenos Aires
M. Nancy Orlando
Hospital de Niños Ricardo Gutiérrez; Universidad de Buenos Aires
Estefanía Josefina Biondi
Hospital de Niños Ricardo Gutiérrez; Universidad de Buenos Aires
Miryam S. Vázquez
Hospital de Niños Ricardo Gutiérrez; Universidad de Buenos Aires
Eduardo L. López
Hospital de Niños Ricardo Gutiérrez; Universidad de Buenos Aires

Published 2019-06-28

How to Cite

1.
Pannunzio ME, Praino ML, M. Carballo C, C. Medranda A, Orlando MN, Biondi EJ, S. Vázquez M, L. López E. Pediatric pyomyositis: Experience in a Pediatric Reference Center in Argentina. Rev. Chilena. Infectol. [Internet]. 2019 Jun. 28 [cited 2026 Jan. 28];36(3). Available from: https://revinf.cl/index.php/revinf/article/view/132

Abstract

Background: Pyomyositis is the infection of skeletal muscle, a rare pathology in children. Aim. To describe the characteristics of pyomyositis in pediatric patients.

Methods: Prospective analytical study of hospitalized children diagnosed with pyomyositis from May 2016 to April 2017 at the Ricardo Gutiérrez Children’s Hospital, Buenos Aires, Argentina.

Results: Twenty-one patients with pyomyositis were identified. Annual rate: 21.5/10,000 admissions (95% CI 4.65-71.43). The median age was 5.4 years (range 1.25-11.6). The lower limbs were the most affected site. C-reactive protein (CRP) was elevated in all patients, with a mean of 124 mg/L (SD 96), being significantly higher in patients with bacteremia: 206 (DS 101) vs 98 (DS 81), p = 0.02. Bacterial cultures were positive in 17/21 (80.9%): 15 methicillin-resistant Staphylococcus aureus (MRSA), and 2 Streptococcus pyogenes. Blood cultures were positive in 5 (23.8%).

Conclusion: MRSA-community acquired is the predominant pathogen in our setting. In the selection of the appropriate empirical treatment, the local resistance pattern and the CRP value should be taken into account.